Martin Louis Wilson - 06 Dec 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
General Counsel
Signature
/s/ Martin Louis Wilson
Issuer symbol
RCKT
Transactions as of
06 Dec 2021
Net transactions value
$0
Form type
4
Filing time
08 Dec 2021, 17:55:24 UTC
Next filing
16 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 06 Dec 2021 Common Stock 100,000 $23.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 100,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on December 6, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.